141 related articles for article (PubMed ID: 10602891)
21. [Severe myalgias: an unusual undesirable effect of levamisole combined with 5-fluorouracil].
Buecher B; Blanc JF; Magnien F; Bechade D; Lapprand M; Oddes B
Gastroenterol Clin Biol; 1996; 20(4):407-8. PubMed ID: 8758514
[No Abstract] [Full Text] [Related]
22. Adjuvant chemotherapy for patients with resected Dukes' C and high-risk B2 colon cancer with fluorouracil and levamisole.
Au E; Ang PT; Seow-Choen F; Soo KC; Low CH; Chng HC; Ng BK
Ann Acad Med Singap; 1998 Sep; 27(5):733-7. PubMed ID: 9919352
[TBL] [Abstract][Full Text] [Related]
23. [Adjuvant chemotherapy in cancer of the colon].
Boni C; Pajetta V
Tumori; 2000; 86(3 Suppl):S20-2. PubMed ID: 10969610
[No Abstract] [Full Text] [Related]
24. A phase I study of 5-fluorouracil, leucovorin and levamisole.
Cleary JF; Arzoomanian R; Alberti D; Feierabend C; Storer B; Witt P; Carbone P; Wilding G
Cancer Chemother Pharmacol; 1997; 39(4):300-6. PubMed ID: 9025770
[TBL] [Abstract][Full Text] [Related]
25. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
Dahl O; Fluge Ø; Carlsen E; Wiig JN; Myrvold HE; Vonen B; Podhorny N; Bjerkeset O; Eide TJ; Halvorsen TB; Tveit KM;
Acta Oncol; 2009; 48(3):368-76. PubMed ID: 19242829
[TBL] [Abstract][Full Text] [Related]
26. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant therapy for colon and rectal cancer.
Ratkin GA
Am Fam Physician; 1997 May; 55(7):2487-92, 2495-6. PubMed ID: 9166147
[TBL] [Abstract][Full Text] [Related]
28. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
O'Connell MJ; Mailliard JA; Kahn MJ; Macdonald JS; Haller DG; Mayer RJ; Wieand HS
J Clin Oncol; 1997 Jan; 15(1):246-50. PubMed ID: 8996149
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M
J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulation with low dose levamisole in patients with colonic polyps.
Holcombe RF; McLaren CE; Milovanovic T
Cancer Detect Prev; 2006; 30(1):94-8. PubMed ID: 16458451
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
Figueredo A; Fine S; Maroun J; Walker-Dilks C; Wong S
Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
[TBL] [Abstract][Full Text] [Related]
32. Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.
Ahnen DJ; Feigl P; Quan G; Fenoglio-Preiser C; Lovato LC; Bunn PA; Stemmerman G; Wells JD; Macdonald JS; Meyskens FL
Cancer Res; 1998 Mar; 58(6):1149-58. PubMed ID: 9515799
[TBL] [Abstract][Full Text] [Related]
33. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
34. A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
Papadimitriou CA; Papakostas P; Karina M; Malettou L; Dimopoulos MA; Pentheroudakis G; Samantas E; Bamias A; Miliaras D; Basdanis G; Xiros N; Klouvas G; Bafaloukos D; Kafiri G; Papaspirou I; Pectasides D; Karanikiotis C; Economopoulos T; Efstratiou I; Korantzis I; Pisanidis N; Makatsoris T; Matsiakou F; Aravantinos G; Kalofonos HP; Fountzilas G
BMC Med; 2011 Jan; 9():10. PubMed ID: 21281463
[TBL] [Abstract][Full Text] [Related]
35. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF
JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899
[TBL] [Abstract][Full Text] [Related]
36. Levamisole and interleukin-2 for advanced malignancy.
Holcombe RF; Li A; Stewart RM
Biotherapy; 1998; 11(4):255-8. PubMed ID: 9950101
[TBL] [Abstract][Full Text] [Related]
37. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.
Moertel CG; Fleming TR; Macdonald JS; Haller DG; Laurie JA; Goodman PJ; Ungerleider JS; Emerson WA; Tormey DC; Glick JH
N Engl J Med; 1990 Feb; 322(6):352-8. PubMed ID: 2300087
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant continuous infusion 5-FU, whole-abdominal radiation, and tumor bed boost in high-risk stage III colon carcinoma: a Southwest Oncology Group Pilot study.
Fabian C; Giri S; Estes N; Tangen CM; Poplin E; Vogel S; Goodwin W; Rivkin S; Fleming TR; Macdonald JS
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):457-64. PubMed ID: 7751186
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin.
Dencausse Y; Hartung G; Sturm J; Kopp-Schneider A; Hagmüller E; Wojatschek C; Lindemann H; Fritze D; Queisser W
Onkologie; 2002 Oct; 25(5):426-30. PubMed ID: 12415196
[TBL] [Abstract][Full Text] [Related]
40. Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer.
Hestetun KE; Brydøy M; Myklebust MP; Dahl O
Acta Oncol; 2015 Apr; 54(4):470-9. PubMed ID: 25227897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
